Physician profile
Jennie E Draper
NPI 1598955924
$2,691.85
in general payments reported to CMS, 2019-2025
36 companies · $945 in 2025
The $945 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $266 · 2021: $37.88 · 2022: $186 · 2023: $272 · 2024: $628 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201 · Travel and Lodging: $598 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.84 |
| Travel and Lodging | $598.36 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $791.90 | 2023-2025 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $183.47 | 2022-2024 | Aptima |
| Lilly USA, LLC | $139.75 | 2024 | Zepbound |
| Exeltis, USA INC. | $124.22 | 2019-2025 | Slynd |
| Daiichi Sankyo INC. | $111.75 | 2019-2024 | Injectafer |
| Shield Therapeutics INC | $102.91 | 2023-2025 | |
| Monaghan Medical Corporation | $101.65 | 2024 | Aeroeclipse |
| Astellas Pharma US INC | $97.15 | 2020-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $92.26 | 2019-2025 | |
| Abbvie INC. | $91.17 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Millicent US INC | $78.29 | 2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $75.03 | 2023-2024 | Gemtesa |
| Northgate Technologies, INC. | $74.20 | 2024 | Stimsite |
| Amag Pharmaceuticals, INC. | $66.46 | 2019 | |
| Pfizer INC. | $50.10 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $44.38 | 2019-2020 | |
| Axonics, INC. | $43.72 | 2020 | |
| Avion Pharmaceuticals | $36.65 | 2019 | |
| Coopersurgical, INC. | $36.50 | 2019-2024 | Paragard T 380a |
| Biogen, INC. | $33.74 | 2025 | Zurzuvae |
| Ambu INC. | $30.87 | 2023 | |
| Allergan, INC. | $30.30 | 2019 | |
| Merck Sharp & Dohme LLC | $28.99 | 2020 | |
| Medicem INC. | $23.15 | 2021 | |
| Amgen INC. | $22.43 | 2025 | Evenity |
| Mylan Pharmaceuticals INC. | $20.45 | 2019 | |
| Novo Nordisk INC | $20.29 | 2024 | |
| Myovant Sciences INC. | $20.25 | 2022 | |
| Medtronic, INC. | $18.88 | 2023 | Venaseal |
| Convatec INC. | $17.52 | 2024 | |
| Lupin INC. | $15.18 | 2020 | |
| Renovia INC | $14.73 | 2021 | |
| Radius Health, INC. | $14.48 | 2019 | |
| Meditrina | $13.78 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.00 | 2020 | |
| Mayne Pharma Commercial LLC | $12.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennie Draper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.